Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.87 |
| ▸ | CHAT | P28329 | 2/20 | 0.83 |
| ▸ | EP300 | Q09472 | 3/20 | 0.82 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.82 |
| ▸ | AURKA | O14965 | 2/20 | 0.82 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.82 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.73 |
| ▸ | NAA40 | Q86UY6 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18925864 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2933622 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL19554420 | 1.00 | NAA50 (0.87) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL28659513 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL15693003 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL30932695 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2483741 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL17279149 | 0.98 | NAA50 (0.86) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL15263879 | 0.98 | NAA50 (0.92) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL6008385 | 0.98 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1584 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106119113-B | Organisms for the production of 1, 3-butanediol | 基因组股份公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260125717-A1 | Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized Polyhydroxybutyrate | KIMBERLY CLARK CO (US) | 2026-05-07 | — | — | US | claimed |
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | GENOMATICA, INC. (US) | 2026-03-17 | — | — | US | claimed |
| US-20250382590-A1 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USING SAME | AGAIN BIO APS (DK) | 2025-12-18 | — | — | US | claimed |
| EP-4662192-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | Genomatica, Inc. (US) | 2025-12-17 | — | — | EP | claimed |
| US-20250368968-A1 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | AGAIN BIO APS (DK) | 2025-12-04 | — | — | US | claimed |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | AGAIN BIO APS (DK) | 2025-11-27 | — | — | US | claimed |
| EP-4642908-A2 | LIGASE AND DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. (US) | 2025-11-05 | — | — | EP | claimed |
| US-20250327099-A1 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | AGAIN BIO APS (DK) | 2025-10-23 | — | — | US | claimed |
| US-20250320531-A1 | MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO | AGAIN BIO APS (DK) | 2025-10-16 | — | — | US | claimed |
| US-20090155869-A1 | ENGINEERED MICROORGANISMS FOR PRODUCING N-BUTANOL AND RELATED METHODS | GEVO, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090111154-A1 | BUTANOL PRODUCTION BY RECOMBINANT MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-30 | — | — | US | claimed |
| WO-2008143704-A2 | ENGINEERED MICROORGANISMS FOR PRODUCING N-BUTANOL AND RELATED METHODS | GEVO, INC. (US) | 2008-11-27 | — | — | WO | claimed |
| WO-2008124523-A1 | BUTANOL PRODUCTION BY RECOMBINANT MICROORGANISMS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-10-16 | — | — | WO | claimed |
| WO-2008062995-A1 | COPOLYMER COMPRISING 4-HYDROXYBUTYRATE UNIT AND LACTATE UNIT AND ITS MANUFACTURING METHOD | LG CHEM, LTD. (KR) | 2008-05-29 | — | — | WO | claimed |
| EP-1159435-A1 | MULTIGENE EXPRESSION VECTORS FOR THE BIOSYNTHESIS OF PRODUCTS VIA MULTIENZYME BIOLOGICAL PATHWAYS | Monsanto Technology LLC (US) | 2001-12-05 | — | — | EP | claimed |
| US-6117658-A | PROVIDING HOST CELL CONTAINING RECOMBINANT NUCLEOTIDE SEQUENCE THAT ENCODES POLYHYDROXYALKANOATE BIOSYNTHETIC PATHWAY AND SEQUENCE THAT ENCODES SUCCINIC SEMIALDEHYDE METABOLIC PATHWAY THAT METABOLIZES SUCCINIC SEMIALDEHYDE, CULTURING | JAMES MADISON UNIVERSITY (US) | 2000-09-12 | — | — | US | claimed |
| WO-2000052183-A1 | MULTIGENE EXPRESSION VECTORS FOR THE BIOSYNTHESIS OF PRODUCTS VIA MULTIENZYME BIOLOGICAL PATHWAYS | MONSANTO TECHNOLOGY LLC (US) | 2000-09-08 | — | — | WO | claimed |
| EP-0977865-A1 | METHODS OF MAKING POLYHYDROXYALKANOATES COMPRISING 4-HYDROXYBUTYRATE MONOMER UNITS | James Madison University (US) | 2000-02-09 | — | — | EP | claimed |
| WO-1998036078-A1 | METHODS OF MAKING POLYHYDROXYALKANOATES COMPRISING 4-HYDROXYBUTYRATE MONOMER UNITS | JAMES MADISON UNIVERSITY (US) | 1998-08-20 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577591-B2 | Microorganisms and methods for increasing co-factors | ABAT, HADHB, MMAB | NAA50 278/4885CHAT 1499/4885EP300 3766/4885 |
| US-20250361531-A1 | MICROORGANISMS AND METHODS FOR PRODUCTION OF 4-HYDROXYBUTYRATE, 1,4-BUTANEDIOL AND RELATED COMPOUNDS | HSD17B10, HSD17B12, HADHB | NAA50 1030/4885CHAT 2185/4885EP300 2217/4885 |
| US-20260125717-A1 | Bioreactor and Process for Forming Polyhydroxybutyrate Directly from Depolymerized Polyhydroxybutyrate | CMBL, AGL, HPD | NAA50 3597/4885CHAT 4110/4885EP300 3598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.